# Determining the Impact of Penicillin in Latent RHD: The GOAL Trial

Study · id `cardio:ct-nct03346525` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03346525](<https://clinicaltrials.gov/study/NCT03346525>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03346525

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 807 participants.

## Technical summary

Registry record NCT03346525. Randomized; single masking; primary purpose treatment. Start 2018-06-26 (actual); primary completion 2020-11-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 807 participants (enrolled count; ClinicalTrials.gov record NCT03346525, source copy `cardio:ctgov-nct03346525-2019-10-01`, retrieved 2026-10-26)
- Started: 2018-06-26 (actual) (ClinicalTrials.gov record NCT03346525, source copy `cardio:ctgov-nct03346525-2019-10-01`, retrieved 2026-10-26)
- Primary completion: 2020-11-30 (anticipated) (ClinicalTrials.gov record NCT03346525, source copy `cardio:ctgov-nct03346525-2019-10-01`, retrieved 2026-10-26)
- Completion: 2020-11-30 (anticipated) (ClinicalTrials.gov record NCT03346525, source copy `cardio:ctgov-nct03346525-2019-10-01`, retrieved 2026-10-26)
- Countries: Uganda (ClinicalTrials.gov record NCT03346525, source copy `cardio:ctgov-nct03346525-2019-10-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03346525-2019-10-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Determining the Impact of Penicillin in Latent RHD: The GOAL Trial
- Acronym: GOAL
- Condition: Rheumatic Heart Disease in Children
- Condition: Latent Rheumatic Heart Disease
- Condition: Rheumatic Heart Disease
- Condition: Heart Diseases
- Intervention (Drug): intramuscular benzathine penicillin G (BPG) prophylaxis
- Lead sponsor: Children's National Research Institute
- Lead sponsor class: OTHER
- Collaborator: Thrasher Research Fund
- Collaborator class: OTHER
- Collaborator: University of Cape Town
- Collaborator class: OTHER
- Collaborator: Uganda Heart Institute
- Collaborator class: OTHER
- Collaborator: Karp Family Foundation
- Collaborator class: UNKNOWN
- Collaborator: Gift of Life International
- Collaborator class: OTHER
- Collaborator: Murdoch Childrens Research Institute
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Rheumatic heart disease (`cardio:rheumatic-heart-disease`)
- Registry lists this organization as a collaborator: University of Cape Town (`cardio:org-university-of-cape-town`)
- Registry lists this organization as a collaborator: Uganda Heart Institute (`cardio:org-uganda-heart-institute`)
- Registry lists this organization as a collaborator: Murdoch Childrens Research Institute (`cardio:org-murdoch-childrens-research-institute`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart Disease (`cardio:pubmed-34767321`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 313de4bd0d160cba2c4fbab872c99060356d68ed4f34abd4c8bd4a8b24642eee
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
